G9a Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of G9a Antibodies for advanced research in epigenetics and gene regulation. G9a Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). G9a, also known as EHMT2, is a histone methyltransferase that plays a crucial role in the regulation of gene expression through the methylation of histone H3 at lysine 9. G9a functions in various biological processes, including development, differentiation, and cellular response to environmental stimuli. Research has shown that G9a activity influences multiple cellular pathways and signaling mechanisms. Dysregulation of G9a has been implicated in several diseases, including cancer, making it a significant target for therapeutic intervention. Understanding G9a's role in normal cellular function and disease progression requires precise detection and analysis methods. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of epigenetic regulation and contribute to the development of new therapeutic strategies.